These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14259235)

  • 1. AN ATTEMPT TO MEASURE SPASTICITY OBJECTIVELY AND THE EFFECT ON THESE MEASUREMENTS OF CARISOPRODOL.
    CAMPBELL ED; GREEN EA
    Ann Phys Med; 1965 Feb; 8():4-11. PubMed ID: 14259235
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF CARISOPRODOL FOR THE TREATMENT OF SPASTICITY IN THE MENTALLY SUBNORMAL.
    GREEN EA
    J Ment Defic Res; 1964 Dec; 8():SUPPL:136-43. PubMed ID: 14248577
    [No Abstract]   [Full Text] [Related]  

  • 3. THE PHYSIOLOGY OF MUSCLE SPASM AS RELATED TO LOW BACK PAIN.
    BOUMAN HD
    South Med J; 1965 Apr; 58():534-8. PubMed ID: 14276448
    [No Abstract]   [Full Text] [Related]  

  • 4. USE OF CARISOPRODOL IN SYMPTOMATIC THERAPY OF PAINFUL MUSCLE SPASM.
    GREADY DM
    Ind Med Surg; 1965 Aug; 34():617-9. PubMed ID: 14334173
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscular spasm and pain. The use of carisoprodol (Soma) in industrial and general practice.
    TUREK L
    Med Times; 1960 Nov; 88():1327-31. PubMed ID: 13778672
    [No Abstract]   [Full Text] [Related]  

  • 6. Carisoprodol for muscular spasm and pain seen in industrial and general practice.
    TUREK LH
    Clin Med (Northfield); 1961 Sep; 8():1728-33. PubMed ID: 15445542
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICAL EXAMINATION OF THE MUSCLE RELAXANT EFFECT OF VALIUM "ROCHE" IN SPASTIC PATIENTS].
    SCHLAEPFER U; MUMENTHALER M
    Schweiz Med Wochenschr; 1964 Oct; 94():1425-31. PubMed ID: 14333887
    [No Abstract]   [Full Text] [Related]  

  • 8. CARISOPRODOL IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS IN A GENERAL PRACTICE. (A CONTROLLED TRIAL).
    LAWRENCE GB; FORSYTH JI
    Br J Clin Pract; 1964 Oct; 18():603-4. PubMed ID: 14209349
    [No Abstract]   [Full Text] [Related]  

  • 9. TREATMENT OF SPASTICITY BY SUBARACHNOID PHENOLGLYCERIN.
    PEDERSEN E; JUUL-JENSEN P
    Neurology; 1965 Mar; 15():256-62. PubMed ID: 14262324
    [No Abstract]   [Full Text] [Related]  

  • 10. SOMA POTENTIALS AND MODES OF ACTIVATION OF CRAYFISH MOTONEURONS.
    TAKEDA K; KENNEDY D
    J Cell Comp Physiol; 1964 Oct; 64():165-81. PubMed ID: 14219651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spasticity. Theoretical considerations for a new therapy].
    Hufschmidt HJ
    Nervenarzt; 1968 Jan; 39(1):2-10. PubMed ID: 4231452
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm.
    Serfer GT; Wheeler WJ; Sacks HJ
    Curr Med Res Opin; 2010 Jan; 26(1):91-9. PubMed ID: 19908948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 14. EVALUATION OF DIAZEPAM (VALIUM) IN THE SYMPTOMATIC TREATMENT OF RHEUMATIC DISORDERS. A CONTROLLED COMPARATIVE STUDY.
    TARPLEY EL
    J Chronic Dis; 1965 Jan; 18():99-106. PubMed ID: 14252274
    [No Abstract]   [Full Text] [Related]  

  • 15. ROLE OF RELAXANTS IN TREATMENT OF TRAUMATIC MUSCULOSKELETAL DISORDERS: A DOUBLE-BLIND STUDY OF THREE AGENTS.
    CAZORT RJ
    Curr Ther Res Clin Exp; 1964 Jul; 6():454-8. PubMed ID: 14203276
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
    Ralph L; Look M; Wheeler W; Sacks H
    Curr Med Res Opin; 2008 Feb; 24(2):551-8. PubMed ID: 18194591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological investigation of hemifacial spasm after microvascular decompression: F waves of the facial muscles, blink reflexes, and abnormal muscle responses.
    Ishikawa M; Ohira T; Namiki J; Kobayashi M; Takase M; Kawase T; Toya S
    J Neurosurg; 1997 Apr; 86(4):654-61. PubMed ID: 9120630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carisoprodol in the treatment of muscle spasticity in the elderly.
    Thompson J
    Gerontol Clin (Basel); 1966; 8(2):100-5. PubMed ID: 5332660
    [No Abstract]   [Full Text] [Related]  

  • 19. CARISOPRODOL IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. A CONTROLLED TRIAL.
    COWAN IC; MAPES RE
    Ann Phys Med; 1963 Nov; 7():140-3. PubMed ID: 14074046
    [No Abstract]   [Full Text] [Related]  

  • 20. Motor unit control in movement disorders.
    Petajan JH
    Adv Neurol; 1983; 39():897-905. PubMed ID: 6229163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.